anna caldwell, Author at European Medical Journal - Page 2 of 16

US Targeted Hepatitis B Vaccination Model Linked to Neonatal Infection

US model study suggests a targeted hepatitis B birth-dose strategy could increase neonatal infections unless screening and vaccination remain high.

AI Achieves 99% Accuracy in Brain Tumour Diagnosis

AI and MRI fusion improves brain tumour diagnosis, achieving over 99% accuracy in tumour classification.

Global Hantavirus Threat Low Following Cruise Ship Outbreak, WHO Says

WHO has assessed the risk to the global population as low, following an outbreak of hantavirus on a cruise ship crossing the Atlantic Ocean.

Rapid Immunotherapy Jab for Cancer Rolled Out on NHS

A new, injectable form of pembrolizumab has been rolled out on the NHS, cutting the time of treatment by up to 90%.

Semaglutide Improved Motivation in Patients with Depression

Semaglutide improved motivation in patients with major depressive disorder, holding promise for the treatment of neuropsychiatric disorders characterised by reward dysfunction.

Current Male Infertility Risk Factors Revealed

Researchers collated an updated record of male infertility risk factors in a 2026 umbrella review.

Bereavement Tied to Higher Cardiovascular Disease Risk During COVID-19

Bereavement is associated with increased cardiovascular disease risk, with stronger associations observed during the COVID-19 pandemic.

NHS Introduces New Standards to Cut Avoidable Maternal Deaths

NHS England has set out new maternity care standards aimed at reducing maternal deaths through earlier risk detection, improved specialist access, and strengthened safety monitoring across services.

Health + AI Tech Show: Social Acceptance of AI in Healthcare Settings

AI applications in healthcare see significant public support compared with other sectors, experts said at the Health + AI Tech Show.

LEO Pharma acquires Replay for $50m

LEO Pharma has acquired Replay’s herpes simplex virus gene therapy platform for $50m upfront.